Cargando…

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial

PURPOSE: The first aim of this study was to assess plan quality using a conformity index (CI) and analyse its influence on patient outcome. The second aim was to identify whether clinical and technological factors including planning treatment volume (PTV) volume and treatment delivery method could b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrington, Rhys, Spezi, Emiliano, Gwynne, Sarah, Dutton, Peter, Hurt, Chris, Staffurth, John, Crosby, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744439/ https://www.ncbi.nlm.nih.gov/pubmed/26852238 http://dx.doi.org/10.1186/s13014-016-0594-x

Ejemplares similares

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
por: Carrington, Rhys, et al.
Publicado: (2015)

Driving developments in UK oesophageal radiotherapy through the SCOPE trials
por: Gwynne, S., et al.
Publicado: (2019)

Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer
por: Piazzese, Concetta, et al.
Publicado: (2019)

Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy
por: Wills, Lucy, et al.
Publicado: (2017)

FIELD(RT): an open-source platform for the assessment of target volume delineation in radiation therapy
por: Piazzese, Concetta, et al.
Publicado: (2021)

Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial
por: Fokas, Emmanouil, et al.
Publicado: (2016)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
por: Crosby, T, et al.
Publicado: (2017)

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1
por: Cox, S, et al.
Publicado: (2016)

Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial
por: Adamson, Douglas, et al.
Publicado: (2014)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial
por: Mukherjee, Somnath, et al.
Publicado: (2023)

Assessing radiomic feature robustness to interpolation in (18)F-FDG PET imaging
por: Whybra, Philip, et al.
Publicado: (2019)

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
por: Mukherjee, Somnath, et al.
Publicado: (2021)

Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
por: Adamson, Douglas, et al.
Publicado: (2021)

Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer
por: Foley, Kieran G, et al.
Publicado: (2017)

Evaluation of prognostic models developed using standardised image features from different PET automated segmentation methods
por: Parkinson, Craig, et al.
Publicado: (2018)

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
por: Hurt, Christopher N, et al.
Publicado: (2011)

The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy
por: Cox, Samantha, et al.
Publicado: (2017)

Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer
por: Hurt, Christopher N., et al.
Publicado: (2015)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
por: Mukherjee, Somnath, et al.
Publicado: (2017)

Utilisation of Pareto navigation techniques to calibrate a fully automated radiotherapy treatment planning solution
por: Wheeler, Philip A., et al.
Publicado: (2019)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
por: Hurt, C N, et al.
Publicado: (2017)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
por: Mukherjee, Somnath, et al.
Publicado: (2015)

Commissioning kilovoltage cone‐beam CT beams in a radiation therapy treatment planning system
por: Alaei, Parham, et al.
Publicado: (2012)

Sensitivity of standardised radiomics algorithms to mask generation across different software platforms
por: Whybra, Philip, et al.
Publicado: (2023)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic
por: Jones, C.M., et al.
Publicado: (2020)

The spatial distribution of oesophageal carcinoma in the Transkei, South Africa.
por: Rose, E. F., et al.
Publicado: (1975)

Oesophageal eosinophilia and oesophageal diseases in children: are the limits clear?
por: Diaz-Oliva, Sarah Esther, et al.
Publicado: (2020)

Association of oesophageal radiation dose volume metrics, neutropenia and acute radiation oesophagitis in patients receiving chemoradiotherapy for non-small cell lung cancer
por: Everitt, Sarah, et al.
Publicado: (2016)

Sex hormones and oesophageal adenocarcinoma: influence of childbearing?
por: Lagergren, J, et al.
Publicado: (2005)

Small cell oesophageal carcinoma: an institutional experience and review of the literature
por: Hudson, E, et al.
Publicado: (2007)

Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment
por: Hagens, Eliza R.C., et al.
Publicado: (2020)

Comparison of different calculation techniques for absorbed dose assessment in patient specific peptide receptor radionuclide therapy
por: Finocchiaro, Domenico, et al.
Publicado: (2020)

External Validation of Radiation-Induced Dyspnea Models on Esophageal Cancer Radiotherapy Patients
por: Shi, Zhenwei, et al.
Publicado: (2019)

Characterization of an orthovoltage biological irradiator used for radiobiological research
por: Azimi, Rezvan, et al.
Publicado: (2015)

The temporal and spatial distribution of oesophageal cancer among mineworkers in Southern Africa.
por: Harington, J. S., et al.
Publicado: (1973)

Does aerobic scope influence geographical distribution of teleost fishes?
por: Nati, Julie J H, et al.
Publicado: (2023)

Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
por: Cox, Samantha J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3pup0c4r61vrnmmp1k1ksflpgk